Project 3 >
Mutation Database >
MYH7 mutations >
Ala355Thr
(other names: A355T)
SEQUENCE
| exon |
12 |
|---|
| nucleotide change | G>A |
| nucleotide pos. in exon |
64 |
| nucleotide pos. in
gene |
9601 |
| UCSC Golden Path position |
22968899 |
| amino acid change | AlaİThr |
| charge change |
|
| codon change |
GCC>ACC |
| transcript change |
missense |
| translation change |
substitution |
mutated amplimer sequence:
cacagggattaaggagacaagttttctctccaacttacaagggatctcac
ttacccatcatacttctttttctggggtccgccaatatggggcctcccta
cagaacgcttttgatgtgctgggcttcacttcagaggagaaaaactccat
gtataagctgacaggcAccatcatgcactttggaaacatgaagttcaagc
tgaagcagcgggaggagcaggcggagccagacggcactgaaggtgggagg
caggattcttggggcagctgtaa
Date this novel mutation was originally posted on
this website: 7/6/2001
References and comments
- Barr, Seidman et al., 2001. (this study)
- Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M.
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.
Circulation 2003 May 6;107(17):2227-32. Epub 2003 Apr 21. (PubMed:12707239)
- Val896Met llikely to be a benign polymorphism.
Clinical features of individuals in this study having
the MYH7:Ala355Thr mutation.
| pedigree |
sex |
height (in.) |
weight (lb.) |
age of onset |
age at exam |
NYHA Class |
LVWT, mm. |
LVED |
LVES |
LA |
EF, % |
diagnosis |
| EC |
M |
|
195 |
|
50 |
II |
17 |
45 |
31 |
77 |
65 |
HCM |
citations & disclaimer |
contact us
Last modified: April 24, 2006